The approval follows an independent panel voting 19-0 in support of allowing for the product that reduces or reverses opioid overdoses to be given the OTC stamp. Northwell Health’s Sandeep Kapoor, MD, ...
In a 19-0 vote on Feb. 15, an FDA advisory panel recommended the agency allow Narcan (naloxone) nasal spray, a product used to reduce or reverse opioid overdoses, to be sold over the counter. The drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback